Amelia Evoli

4.7k total citations · 2 hit papers
69 papers, 3.1k citations indexed

About

Amelia Evoli is a scholar working on Neurology, Infectious Diseases and Endocrinology, Diabetes and Metabolism. According to data from OpenAlex, Amelia Evoli has authored 69 papers receiving a total of 3.1k indexed citations (citations by other indexed papers that have themselves been cited), including 67 papers in Neurology, 17 papers in Infectious Diseases and 8 papers in Endocrinology, Diabetes and Metabolism. Recurrent topics in Amelia Evoli's work include Myasthenia Gravis and Thymoma (58 papers), Peripheral Neuropathies and Disorders (36 papers) and Antifungal resistance and susceptibility (16 papers). Amelia Evoli is often cited by papers focused on Myasthenia Gravis and Thymoma (58 papers), Peripheral Neuropathies and Disorders (36 papers) and Antifungal resistance and susceptibility (16 papers). Amelia Evoli collaborates with scholars based in Italy, United States and United Kingdom. Amelia Evoli's co-authors include Valentina Damato, Raffaele Iorio, Paolo Emilio Alboini, Emanuela Bartoccioni, Nils Erik Gilhus, Jacqueline Palace, Chiara Di Schino, Jan J.G.M. Verschuuren, Donald B. Sanders and Pushpa Narayanaswami and has published in prestigious journals such as The Lancet, Journal of Clinical Oncology and Neurology.

In The Last Decade

Amelia Evoli

66 papers receiving 3.1k citations

Hit Papers

International consensus guidance for management of myasth... 2016 2026 2019 2022 2016 2022 200 400 600

Peers

Amelia Evoli
Matthew N. Meriggioli United States
Amelia Evoli
Citations per year, relative to Amelia Evoli Amelia Evoli (= 1×) peers Matthew N. Meriggioli

Countries citing papers authored by Amelia Evoli

Since Specialization
Citations

This map shows the geographic impact of Amelia Evoli's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Amelia Evoli with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Amelia Evoli more than expected).

Fields of papers citing papers by Amelia Evoli

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Amelia Evoli. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Amelia Evoli. The network helps show where Amelia Evoli may publish in the future.

Co-authorship network of co-authors of Amelia Evoli

This figure shows the co-authorship network connecting the top 25 collaborators of Amelia Evoli. A scholar is included among the top collaborators of Amelia Evoli based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Amelia Evoli. Amelia Evoli is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Damato, Valentina, Gregorio Spagni, Gabriele Monte, et al.. (2023). Immunological response after SARS-CoV-2 infection and mRNA vaccines in patients with myasthenia gravis treated with Rituximab. Neuromuscular Disorders. 33(3). 288–294. 5 indexed citations
2.
Punga, Anna Rostedt, Paul Maddison, Jeannine M. Heckmann, Jeffrey T. Guptill, & Amelia Evoli. (2022). Epidemiology, diagnostics, and biomarkers of autoimmune neuromuscular junction disorders. The Lancet Neurology. 21(2). 176–188. 121 indexed citations breakdown →
3.
Spagni, Gregorio, Bo Sun, Gabriele Monte, et al.. (2022). Efficacy and safety of rituximab in myelin oligodendrocyte glycoprotein antibody-associated disorders compared with neuromyelitis optica spectrum disorder: a systematic review and meta-analysis. Journal of Neurology Neurosurgery & Psychiatry. 94(1). 62–69. 16 indexed citations
4.
Assini, Andrea, et al.. (2021). Myasthenia gravis associated with anti‐MuSK antibodies developed after SARS‐CoV‐2 infection. European Journal of Neurology. 28(10). 3537–3539. 41 indexed citations
5.
Damato, Valentina, Gregorio Spagni, Amelia Evoli, et al.. (2021). Clinical features and outcome of patients with autoimmune cerebellar ataxia evaluated with the Scale for the Assessment and Rating of Ataxia. European Journal of Neurology. 29(2). 564–572. 11 indexed citations
6.
Monte, Gabriele, Gregorio Spagni, Valentina Damato, et al.. (2021). Acetylcholine receptor antibody positivity rate in ocular myasthenia gravis: a matter of age?. Journal of Neurology. 268(5). 1803–1807. 15 indexed citations
7.
Spagni, Gregorio, et al.. (2021). Assessing the role of a tissue-based assay in the diagnostic algorithm of autoimmune encephalitis. Journal of Neuroimmunology. 356. 577601–577601. 14 indexed citations
8.
Alboini, Paolo Emilio, Gregorio Spagni, & Amelia Evoli. (2021). In sickness and in health: when myasthenia gravis is a conjugal matter. Neurological Sciences. 42(5). 2099–2101. 2 indexed citations
9.
Iorio, Raffaele, Valentina Damato, Amelia Evoli, et al.. (2017). Clinical and immunological characteristics of the spectrum of GFAP autoimmunity: a case series of 22 patients. Journal of Neurology Neurosurgery & Psychiatry. 89(2). 138–146. 147 indexed citations
10.
Sanders, Donald B., Gil I. Wolfe, Michael Benatar, et al.. (2016). International consensus guidance for management of myasthenia gravis. Neurology. 87(4). 419–425. 710 indexed citations breakdown →
11.
Gallo, Enzo, Stefano Sioletic, Francesco Facciolo, et al.. (2016). Molecular genetic alterations in egfr CA-SSR-1 microsatellite and egfr copy number changes are associated with aggressiveness in thymoma. Journal of Thoracic Disease. 8(3). 386–395. 1 indexed citations
12.
Evoli, Amelia, Pietro Caliandro, Raffaele Iorio, et al.. (2015). Poly-autoimmunity in patients with myasthenia gravis: A single-center experience. Autoimmunity. 48(6). 412–417. 15 indexed citations
13.
Alboini, Paolo Emilio, Valentina Damato, Raffaele Iorio, Marco Luigetti, & Amelia Evoli. (2015). Myasthenia gravis with presynaptic neurophysiological signs: Two case reports and literature review. Neuromuscular Disorders. 25(8). 646–650. 6 indexed citations
14.
Evoli, Amelia, Rocco Liguori, A. Romani, et al.. (2014). Italian recommendations for Lambert–Eaton myasthenic syndrome (LEMS) management. Neurological Sciences. 35(4). 515–520. 12 indexed citations
15.
Iorio, Raffaele, Valentina Damato, Paolo Emilio Alboini, & Amelia Evoli. (2014). Efficacy and safety of rituximab for myasthenia gravis: a systematic review and meta-analysis. Journal of Neurology. 262(5). 1115–1119. 132 indexed citations
16.
Marino, Mariapaola, Gabriele Di Sante, Flavia Scuderi, et al.. (2014). T cell repertoire in DQ5-positive MuSK-positive myasthenia gravis patients. Journal of Autoimmunity. 52. 113–121. 25 indexed citations
17.
Padua, Luca, Amelia Evoli, Irene Aprile, et al.. (2001). Health-related quality of life in patients with myasthenia gravis and the relationship between patient-oriented assessment and conventional measurements. Neurological Sciences. 22(5). 363–369. 68 indexed citations
18.
Padua, Luca, Erik Stålberg, Mauro LoMonaco, et al.. (2000). SFEMG in ocular myasthenia gravis diagnosis. Clinical Neurophysiology. 111(7). 1203–1207. 93 indexed citations
19.
Evoli, Amelia, et al.. (2000). Clinical Characteristics and Prognosis of Myasthenia Gravis in Older People. Journal of the American Geriatrics Society. 48(11). 1442–1448. 59 indexed citations
20.
Sher, Emanuele, N. Canal, G. Piccolo, et al.. (1989). SPECIFICITY OF CALCIUM CHANNEL AUTOANTIBODIES IN LAMBERT-EATON MYASTHENIC SYNDROME. The Lancet. 334(8664). 640–643. 112 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026